Skip to main content
Frontiers in Chemistry logoLink to Frontiers in Chemistry
. 2022 Nov 18;10:1082236. doi: 10.3389/fchem.2022.1082236

Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site

Shoude Zhang 1,2,*, Qiangqiang Jia 1, Qiang Gao 1, Xueru Fan 2, Yuxin Weng 2, Zhanhai Su 1,2,*
PMCID: PMC9717439  PMID: 36465865

In the original article, there was an error in the affiliations as published, in which a third affiliation was wrongly included for author “Shoude Zhang”. The correct affiliations appear above.

In the original article, there was an error in Figure 6, page 4, as published. In the same batch of experiments, WB experiments for two compounds were done at the same time, and the article incorrectly used the results of another drug in the experiments. The corrected Figure 6 and its caption appear below.

FIGURE 6.

FIGURE 6

Inhibition of CDK1 dephosphorylation caused by HB-21. The cells in the G2/M phase were treated with the indicated concentration of HB-21 or DMSO for 4 h, and then harvested. The samples were processed for Western blot analysis.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Chemistry are provided here courtesy of Frontiers Media SA

RESOURCES